Literature DB >> 16325220

Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells.

Michael Belshan1, Lisa A Mahnke, Lee Ratner.   

Abstract

The HIV-2 viral accessory protein Vpx is related to, but distinct from the Vpr protein of HIV-1. Vpx is packaged into virions and as a component of the viral preintegration complex (PIC) is required for efficient virus replication in non-dividing cells. We have previously reported that the minimal transferable region of Vpx that contained karyophilic properties was aa 65 to 72. Analysis of Vpx sequences from various HIV-2/SIV strains reveals that this region contains highly conserved amino acids, including two basic residues (K68, R70) and three tyrosines (Y66, Y69, Y71). Here, we demonstrate that mutation of the basic or tyrosine residues abolishes PIC nuclear import in arrested cells as assessed by PCR detection of viral integration. Examination of cell-free virus by Western blot indicated that all mutant proteins were incorporated into virions, suggesting that the lack of replication in arrested cells was not due to a loss of Vpx in target cells. Together, these studies map critical residues of the Vpx nuclear localization signal that are required for efficient infection of non-dividing cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325220     DOI: 10.1016/j.virol.2005.10.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex.

Authors:  Xiaogang Cheng; Michael Belshan; Lee Ratner
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 2.  Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.

Authors:  Jason L Dehart; Vicente Planelles
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  In vivo biotinylation and capture of HIV-1 matrix and integrase proteins.

Authors:  Michael Belshan; Cameron J Schweitzer; Meghan R Donnellan; Richard Lu; Alan Engelman
Journal:  J Virol Methods       Date:  2009-03-26       Impact factor: 2.014

4.  Functional analysis of the relationship between Vpx and the restriction factor SAMHD1.

Authors:  Gregory Berger; Jocelyn Turpin; Stéphanie Cordeil; Kevin Tartour; Xuan-Nhi Nguyen; Renaud Mahieux; Andrea Cimarelli
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

5.  HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.

Authors:  Anna McCulley; Lee Ratner
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

6.  Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.

Authors:  Caroline Goujon; Vanessa Arfi; Thomas Pertel; Jeremy Luban; Julia Lienard; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

Review 7.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

8.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Nguyen; Baek Kim; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-11-13       Impact factor: 3.616

9.  Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj.

Authors:  Silke Schüle; Björn-Philipp Kloke; Julia K Kaiser; Sabine Heidmeier; Sylvia Panitz; Nina Wolfrum; Klaus Cichutek; Matthias Schweizer
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.